Fig. 1

Polypharmacy prevalence according to a range of definitions (2 to 11 or more medications) during A the first trimester and B the entire pregnancy, among pregnancies of all eligible women and pregnancies of women with multimorbidity, who were followed up completely through the respective periods of prevalence estimation (primary analysis)